Shensong Yangxin (SSYX) ameliorates disordered excitation transmission by suppressing cardiac collagen hyperplasia in rabbits with chronic myocardial infarction.
10.1007/s11596-016-1560-4
- Author:
Song DANG
1
;
Cong-Xin HUANG
2
,
3
;
Xi WANG
1
;
Xin WANG
1
;
Juan HU
1
;
He HUANG
1
Author Information
1. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
2. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huangcongxin@vip.
3. com.
- Publication Type:Journal Article
- Keywords:
Shensong Yangxin;
collagen;
excitation transmission;
hyperplasia;
myocardial infarction
- MeSH:
Animals;
Collagen Type I;
genetics;
metabolism;
Collagen Type III;
genetics;
metabolism;
Drugs, Chinese Herbal;
administration & dosage;
pharmacology;
therapeutic use;
Female;
Heart Rate;
drug effects;
Hyperplasia;
Male;
Matrix Metalloproteinase 2;
genetics;
metabolism;
Myocardial Infarction;
drug therapy;
pathology;
Myocardium;
metabolism;
pathology;
Rabbits;
Transforming Growth Factor beta;
genetics;
metabolism
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2016;36(2):162-167
- CountryChina
- Language:English
-
Abstract:
The traditional Chinese medicine Shensong Yangxin (SSYX) can improve the clinical symptoms of arrhythmia in an integrated manner. This study aimed to investigate the electrophysiological effect of SSYX on the hearts of myocardial-infarcted rabbits and further explore the mechanism by which SSYX alleviates myocardial fibrosis. Myocardial infarction (MI) was established in rabbits by ligation of the left circumflex coronary. The rabbits were treated with SSYX (0.5 g/kg/d) or saline for 8 weeks by oral administration. Microelectrode array (MEA) technology was used in vivo for extracellular electrophysiological recordings of the infarct border zone. Masson's trichrome staining was used to observe myocardial fibrosis. Western blotting was performed to evaluate the protein expression levels of collagen I (COL I) and collagen III (COL III). Quantitative real-time polymerase chain reaction (real-time PCR) was performed to evaluate the TGF-β1 and MMP-2 mRNA expression levels. The results showed that the total activation time (TAT) and the dispersion of TAT were significantly increased and the excitation propagation markedly disordered after MI. SSYX could significantly decrease TAT and the dispersion of TAT, and significantly ameliorate the chaotic spread pattern of excitation. Furthermore, SSYX treatment could significantly decrease COL I and COL III protein levels and down-regulate TGF-β1 and MMP-2 mRNA expression levels in MI rabbits. It was concluded that SSYX may ameliorate cardiac electrophysiological abnormalities in infarcted hearts by decreasing the protein levels of COL I and COL III, down-regulating the mRNA expression levels of TGF-β1 and MMP2, and thereby reducing adverse cardiac remodeling.
